Quanterix Revenue and Competitors
Estimated Revenue & Valuation
- Quanterix's estimated annual revenue is currently $37.6M per year.
- Quanterix received $8.5M in venture funding in August 2017.
- Quanterix's estimated revenue per employee is $74,372
- Quanterix's total funding is $533.3M.
Employee Data
- Quanterix has 506 Employees.
- Quanterix grew their employee count by 23% last year.
Quanterix's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Chief Technology Officer and VP Research | Reveal Email/Phone |
2 | CEO | Reveal Email/Phone |
3 | VP, Enterprise Program Management Office | Reveal Email/Phone |
4 | VP Instrument - Engineering | Reveal Email/Phone |
5 | SVP, Research Products | Reveal Email/Phone |
6 | SVP and General Counsel | Reveal Email/Phone |
7 | SVP, Accelerator & Clinical Services | Reveal Email/Phone |
8 | SVP, General Counsel and Secretary | Reveal Email/Phone |
9 | VP Commercial Operations | Reveal Email/Phone |
10 | VP Sales | Reveal Email/Phone |
Quanterix Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $354.2M | 2285 | 2% | N/A | N/A |
#2 | $46.9M | 242 | -10% | $85.2M | N/A |
What Is Quanterix?
Quanterix is a company that is digitizing biomarker analysis with the goal of advancing the science of precision health. The company's ultra-sensitive detection solution, Simoa, has the potential to change the way in which healthcare is provided today by giving researchers the ability to closely examine the role of biomarkers in the continuum of health to disease. Quanterix technology is designed to enable much earlier disease detection, better prognosis and precise treatment methods to improve the quality of life and longevity of the population for generations to come. The technology is currently being used for research applications in several therapeutic areas, including oncology, neurology, cardiology, inflammation and infectious disease. The company was established in 2007 and is located in Lexington, Massachusetts.
keywords:Analytics,Biotechnology,Enterprise Software,Healthcare,Medical Diagnostics,Pharmaceuticals
$533.3M
Total Funding
506
Number of Employees
$37.6M
Revenue (est)
23%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Quanterix News
Billerica, Massachusetts-based Quanterix designed its Simoa neurofilament light chain (NfL) plasma test as a prognostic aid in assessing the...
Quanterix (NASDAQ:QTRX) on Friday said its Simoa neurofilament light chain plasma test has been granted Breakthrough Device designation by...
Quanterix is a company that's digitizing biomarker analysis with the goal of advancing the science of precision health. The company's digital...
Q1 GAAP revenue including grant revenue $27.2M; Q1 non-GAAP revenue $24.9M, an increase of 58% versus prior year Billerica, Mass. -May 5, 2021 - Quanterix Corporation (NASDAQ: QTRX), a company helping to transform healthcare with digital protein biomarker technology enabling precision health, t ...
Q1 GAAP revenue including grant revenue $27.2M; Q1 non-GAAP revenue $24.9M, an increase of 58% versus prior year Billerica, Mass. -May 5, 2021 - Quanterix Corporation (NASDAQ: QTRX), a company helping to transform healthcare with digital protein biomarker technology enabling precision health, t ...
Other Companies in Lexington
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $205.6M | 506 | 6% | N/A |
#2 | $171.1M | 507 | 8% | N/A |
#3 | $64.5M | 516 | -5% | N/A |
#4 | $177.2M | 525 | 3% | N/A |
#5 | $113.3M | 556 | 22% | N/A |
Quanterix Funding
| Date | Amount | Round | Lead Investors | Reference |
|---|---|---|---|---|
| 2008-08-26 | $15.0M | A | ARCH Venture Partners, Bain Capital Ventures | Article |
| 2016-03-24 | $46.0M | D | ARCH Overage Fund | Article |
| 2017-08-04 | $8.5M | Undisclosed | T. Rowe Price Associates, Inc. | Article |